openPR Logo
Press release

Global Asthma and COPD Drug Market - The Fundamentals and Overview

05-09-2016 12:29 PM CET | Health & Medicine

Press release from: Transparency Market Research

Global Asthma and COPD Drug Market - The Fundamentals

According to the World Health Organization, asthma is the most common chronic disease among children. While around 235 million people worldwide suffer from asthma, the disease is often under-diagnosed and under-treated, creating considerable burden to families and individuals and restrict daily activities to a certain extent.

Chronic obstructive pulmonary disease (COPD), a life-threatening lung disease, killed over 3 million people in 2012, with over 90.0% deaths occurring in low and middle-income nations, according to the WHO.

Get Free Sample Research Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=145

Medication and appropriate management can control asthma and COPD, avoiding triggers that spike the severity of the disease, thereby enabling people to enjoy a good quality of life. Even though COPD is not curable, effective drugs and other treatments can slow the progress of the disease.

The report on asthma and COPD drugs market studies the development of novel drugs and various innovative treatment options. The contribution and performance of leading branded drugs in the market is evaluated at length, highlighting factors that work in favor of the asthma and COPD drugs market and those that hamper its growth.

Overview of the Asthma and COPD Drug Market

The report states that developing at a tepid 1.03% CAGR from 2010 to 2017, the global market for asthma and COPD drugs is poised to grow from a value of US$25,102.3 mn in 2010 to US$26,965.5 mn in 2017.

Factors such as alarming levels of air pollution, daily exposure to hazardous working environments, rise in aging population susceptible to air pollutants, increasing population of smokers, growing influx of air pollutants, rise in healthcare expenditure, strong research and development activities, rise in disposable income, and favorable government initiatives have continued to boost the global asthma and COPD drugs market. However, high cost of asthma treatment, patent expiry of several blockbuster brands, significant section of uninsured population, and long treatment duration threaten to impede the growth of the asthma and COPD drugs market.

In 2010, Asia Pacific dominated the global market, with China emerging among the top ranking countries owing to rising number of asthma patients. Rapid urbanization, air pollution, change in lifestyle, and rise in smoking population has resulted in higher occurrence of asthma symptoms in urban China, thereby fueling the demand for asthma and COPD drugs. During the forecast period of 2010 to 2017, North America is anticipated to record the highest CAGR of 3.90% owing to factors similar to China.

Companies Mentioned in the Report

Some of the major companies competing in the asthma and COPD drug market are Mylan, GlaxoSmithKline, Amgen, Dr. Reddy’s Laboratories, Aurobindo, AptarGroup, Pfizer, Vectura, Ranbaxy, F. Hoffmann-La Roche, Cipla, AstraZeneca, Novartis, Abbott, Boehringer Ingelheim, Actavis, Merck, Sunovion, and Glenmark. The most prominent players are profiled in the research report based on aspects such as company overview, business strategies, recent developments, product portfolio, and financial performance.

Full Research Report on Global Asthma and COPD Drug Market:
http://www.transparencymarketresearch.com/asthma-and-copd-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

90 State Street, Suite 700 Albany, NY 12207

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Asthma and COPD Drug Market - The Fundamentals and Overview here

News-ID: 338995 • Views:

More Releases from Transparency Market Research

Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
The latest research study released by Transparency Market Research on "Solid Tires Market Forecast to 2023-2031 ″ research provides accurate economic, global, and country-level predictions and analyses. Solid Tires market is estimated to attain a valuation of US$ 760.0 Mn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 8.1% during
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031| Says Transparency Market Research
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031 …
The latest research study released by Transparency Market Research on "𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐂𝐲𝐛𝐞𝐫 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Automotive Cyber security industry, as
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from 2022 to 2031: TMR Study
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from …
The latest research study released by Transparency Market Research on "𝐑𝐞𝐚𝐝𝐲-𝐦𝐢𝐱 𝐂𝐨𝐧𝐜𝐫𝐞𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Ready-mix Concrete industry, as well as
Mining Automation Market to Surge at 6.4% CAGR, Hitting US$ 7.3 Bn by 2031, According to TMR Study
Mining Automation Market to Surge at 6.4% CAGR, Hitting US$ 7.3 Bn by 2031, Acco …
The latest research study released by Transparency Market Research on "𝐌𝐢𝐧𝐢𝐧𝐠 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Mining Automation industry, as well as

All 5 Releases


More Releases for COPD

Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's. It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the
04-10-2017 | Health & Medicine
TMR
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the